Impact of a single or two dose regimen of inclisiran, a novel siRNA inhibitor to PCSK9 on time averaged reductions in LDL-C over 1 year. ORION 1
Topic:
Lipids (Epidemiology and Prevention)
Speaker:
Professor K. Ray (London, GB)
Event:
ESC Congress 2017
Congress Presentation
About the speaker
Professor Kausik K Ray
Imperial College London, London (United Kingdom of Great Britain & Northern Ireland)
77
presentations
11
followers
17 more presentations in this session
Access the full session
Hot Line: Late-Breaking Clinical Trials 2
Speakers:
Professor K. Ray, Professor M. Boehm, Professor B. Williams, Professor M. Ezekowitz, Professor J. Nielsen
About the event
ESC 365 is supported by
